All posts by: Michael Zand

About Michael Zand

Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi … – GlobeNewswire (press release)

Continue reading

2017-03-10 NEWS

Zacks.com

Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug Conjugate Bi …
GlobeNewswire (press release)
The aim of the research collaboration is to join Endocyte’s SMDC bi-specific adaptor technology with the CAR T-cell immunotherapy research efforts at the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute, to move …
Endocyte Reports Fourth Quarter and Year End 2016 Financial Results and Provides Clinical and Pipeline UpdateNasdaq

all 11 news articles »

Continue reading

2017-03-10 NEWS

Genetic Engineering & Biotechnology News

Immunotherapy Zaps Tasmanian Devils’ Facial Tumors
Genetic Engineering & Biotechnology News
An international study involving multiple institutions over six years has shown that immunotherapy can cure Tasmanian devils of the deadly devil facial tumor disease (DFTD). The research was led by the University of Tasmania’s Menzies Institute for
Immunotherapy trial cures Tasmanian devils of DFTDScience Daily
Breakthrough offers hope for Tasmanian devil cancer cureBBC News
Tasmanian devils helped to fight off facial tumour disease with live …ABC Online
The Mercury –9news.com.au
all 12 news articles »
Continue reading

2017-03-10 NEWS

Genetic Engineering & Biotechnology News

Immunotherapy Zaps Tasmanian Devils’ Facial Tumors
Genetic Engineering & Biotechnology News
An international study involving multiple institutions over six years has shown that immunotherapy can cure Tasmanian devils of the deadly devil facial tumor disease (DFTD). The research was led by the University of Tasmania’s Menzies Institute for
Immunotherapy trial cures Tasmanian devils of DFTDScience Daily
Breakthrough offers hope for Tasmanian devil cancer cureBBC News
Tasmanian devils helped to fight off facial tumour disease with live …ABC Online
The Mercury –9news.com.au
all 12 news articles »
Continue reading

2017-03-10 NEWS

SMA News Today

SMN Gene Therapy (Genzyme Sanofi)
SMA News Today
Genzyme’s current investigational program is focused on the delivery of the AAV9-SMN gene into cerebrospinal fluid. Work in mouse models of SMA has shown that delivery of AAV9-SMN1 into the cerebrospinal fluid results in a transfer of the gene to the …

and more »

Continue reading

2017-03-10 NEWS

Learn about ‘CRISPR‘ gene-editing with RadioLab’s podcast
UConn Daily Campus
The podcast titled “Update: CRISPR” was a long-overdue sequel to a previous story RadioLab released two summers ago. The latest show was produced and hosted by Molly Webster and Soren Wheeler, with notable guests like the New York Times science …